| Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. GS Hotamisligil, P Arner, JF Caro, RL Atkinson, BM Spiegelman The Journal of clinical investigation 95 (5), 2409-2415, 1995 | 4982 | 1995 |
| The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes HH Parving, H Lehnert, J Bröchner-Mortensen, R Gomis, S Andersen, ... New England Journal of Medicine 345 (12), 870-878, 2001 | 4541 | 2001 |
| Dynamics of fat cell turnover in humans KL Spalding, E Arner, PO Westermark, S Bernard, BA Buchholz, ... Nature 453 (7196), 783-787, 2008 | 3009 | 2008 |
| A promoter-level mammalian expression atlas Nature 507 (7493), 462-470, 2014 | 1766 | 2014 |
| Genome-wide analysis of mammalian promoter architecture and evolution P Carninci, A Sandelin, B Lenhard, S Katayama, K Shimokawa, ... Nature genetics 38 (6), 626-635, 2006 | 1649 | 2006 |
| Overexpression of the obese (ob) gene in adipose tissue of human obese subjects F Lönnqvist, P Arner, L Nordfors, M Schalling Nature medicine 1 (9), 950-953, 1995 | 1025 | 1995 |
| Leptin secretion from subcutaneous and visceral adipose tissue in women. V Van Harmelen, S Reynisdottir, P Eriksson, A Thörne, J Hoffstedt, ... Diabetes 47 (6), 913-917, 1998 | 841 | 1998 |
| Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease J Moss, J Magenheim, D Neiman, H Zemmour, N Loyfer, A Korach, ... Nature communications 9 (1), 5068, 2018 | 793 | 2018 |
| Adipocyte turnover: relevance to human adipose tissue morphology E Arner, PO Westermark, KL Spalding, T Britton, M Rydén, J Frisén, ... Diabetes 59 (1), 105-109, 2010 | 789 | 2010 |
| Tissue distribution of beta 3-adrenergic receptor mRNA in man. S Krief, F Lönnqvist, S Raimbault, B Baude, A Van Spronsen, P Arner, ... The Journal of clinical investigation 91 (1), 344-349, 1993 | 742 | 1993 |
| Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome D Lamers, S Famulla, N Wronkowitz, S Hartwig, S Lehr, DM Ouwens, ... Diabetes 60 (7), 1917-1925, 2011 | 698 | 2011 |
| Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells E Arner, CO Daub, K Vitting-Seerup, R Andersson, B Lilje, F Drabløs, ... Science 347 (6225), 1010-1014, 2015 | 625 | 2015 |
| The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones P Arner Trends in Endocrinology & Metabolism 14 (3), 137-145, 2003 | 622 | 2003 |
| Treatment With Dietary trans10cis12 Conjugated Linoleic Acid Causes Isomer-Specific Insulin Resistance in Obese Men With the Metabolic Syndrome ULF RISerus, P Arner, K Brismar, B Vessby Diabetes care 25 (9), 1516-1521, 2002 | 611 | 2002 |
| Differences in lipolysis between human subcutaneous and omental adipose tissues P Arner Annals of medicine 27 (4), 435-438, 1995 | 608 | 1995 |
| Human fat cell lipolysis: biochemistry, regulation and clinical role P Arner Best practice & research Clinical endocrinology & metabolism 19 (4), 471-482, 2005 | 595 | 2005 |
| An integrated expression atlas of miRNAs and their promoters in human and mouse D De Rie, I Abugessaisa, T Alam, E Arner, P Arner, H Ashoor, G Åström, ... Nature biotechnology 35 (9), 872-878, 2017 | 591 | 2017 |
| Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells H Sell, J Laurencikiene, A Taube, K Eckardt, A Cramer, A Horrighs, ... Diabetes 58 (12), 2731-2740, 2009 | 580 | 2009 |
| Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial H Bjermo, D Iggman, J Kullberg, I Dahlman, L Johansson, L Persson, ... The American journal of clinical nutrition 95 (5), 1003-1012, 2012 | 578 | 2012 |
| Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. V Large, L Hellström, S Reynisdottir, F Lönnqvist, P Eriksson, L Lannfelt, ... The Journal of clinical investigation 100 (12), 3005-3013, 1997 | 548 | 1997 |
Fredrik LonnqvistAssociate Professor Karolinska Institutet, CMO at QuicktestVerified email at quicktest.se